Gilead
-
Kaohoon International
WHO Goes Against Gilead’s Remdesivir as the Drug Shows No Sign of Improving Survivability
WHO Goes Against Gilead’s Remdesivir as the Drug Shows No Sign of Improving Survival Rates.
-
Kaohoon International
Asia Stocks Edge Higher, Shaking Off a Single-Day High of Coronavirus Cases Stateside
Asia Stocks Edge Higher, Shaking Off a Single-Day High of Coronavirus Cases Stateside as Hopes on Gilead's Remdesivir Rise.